| Mar'20 | Dec'19 | Sep'19 | Jun'19 | Mar'19 | Dec'18 | Sep'18 | Jun'18 | Mar'18 | Sep'17 | Jun'17 | Dec'16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
Operating expenses: | |||||||||||
Research and development | |||||||||||
9,090 | 8,463 | 7,324 | 10,550 | 10,022 | 4,965 | 4,140 | 9,161 | 4,383 | 887 | 3,731 | - |
General and administrative | |||||||||||
3,775 | 2,420 | 2,649 | 1,707 | 1,237 | 1,236 | 1,272 | 1,004 | 653 | 488 | 256 | 165 |
Total operating expenses | |||||||||||
12,865 | 10,883 | 9,973 | 12,257 | 11,259 | 6,201 | 5,412 | 10,165 | 5,036 | 1,375 | 3,987 | 165 |
Loss from operations | |||||||||||
-12,865 | -10,883 | -9,973 | -12,257 | -11,259 | -6,201 | -5,412 | -10,165 | -5,036 | -1,375 | -3,987 | -165 |
Interest income | |||||||||||
283 | 343 | 204 | 253 | 287 | - | 237 | 45 | - | - | - | - |
Interest income | |||||||||||
- | - | - | - | - | - | - | - | 57 | 50 | 30 | - |
Change in fair value of warrant liability | |||||||||||
- | - | - | - | - | 0 | 217 | 219 | 84 | 37 | 86 | - |
Loss before income tax benefit | |||||||||||
-12,582 | -10,540 | -9,769 | -12,004 | -10,972 | -5,871 | -5,392 | -10,339 | -5,063 | - | - | -165 |
Net loss | |||||||||||
-12,582 | - | - | - | -10,972 | - | - | - | - | - | - | - |
Accretion on Series A Convertible Redeemable Preferred Stock | |||||||||||
- | - | - | - | - | 0 | 25 | 126 | 125 | 127 | 90 | - |
Net loss attributable to common stockholders | |||||||||||
- | - | -9,769 | -12,004 | - | -5,684 | -5,417 | -10,465 | -5,188 | -1,489 | -4,133 | -165 |
Net loss per common share, basic and diluted | |||||||||||
-0.26 | -0.21 | -0.24 | -0.32 | -0.29 | 0.55 | -0.17 | -1.05 | -0.52 | -0.15 | -0.44 | -0.02 |
Weighted average common shares outstanding, basic and diluted | |||||||||||
47 | 85,075 | 40,512 | 37,363 | 37 | 37,764 | 32,000 | 10,000 | 10,000 | 10,000 | 9,473 | 7,636 |
Other income (expense), net | |||||||||||
- | - | - | - | - | - | - | - | - | 13 | -56 | - |
Net Loss | |||||||||||
-12,582 | -10,540 | -9,769 | -12,004 | -10,972 | -5,684 | -5,392 | -10,339 | -5,063 | -1,362 | -4,043 | -165 |
Other comprehensive income: | |||||||||||
Unrealized gain on marketable securities | |||||||||||
210 | - | - | - | - | - | - | - | - | - | - | - |
Total comprehensive loss | |||||||||||
-12,372 | - | - | - | -10,972 | - | - | - | - | - | - | - |